BOB SHEPLER

S 2420/HR 4710 - No Surprises Act Enforcement Act including issues related to independent dispute resolution abuse; S (not yet introduced)/HR 10788 - Lower Premiums, Faster Payments Act including issues related to the appeals process

S 1173/HR 2199 - Restore Protections for Dialysis Patients Act including issues related to Medicare secondary payer issues; S 2420/HR 4710 - No Surprises Act Enforcement Act including issues related to independent dispute resolution abuse

S 1173/HR 2199 - Restore Protections for Dialysis Patients Act including issues related to Medicare and secondary payer; HR 4317 - PBM Reform Act of 2025 including issues related to healthcare; HR 7148 - Consolidated Appropriations Act, 2026 including issues related to Pharmacy Benefit Manager issues

S 4784/HR 8800 - National Defense Authorization Act for Fiscal Year 2027 including issues related to electromagnetic spectrum, acquisition policy, missile defense, classified programs, strategic programs, tactical fixed wing aviation programs, transport aircraft, helicopters, land sea and air based tactical missiles, integrated air and radars and sensors, electronic warfare systems, military space, cyber, technology, intelligence, Foreign Military Sales (FMS), Direct Commercial Sales (DCS), procurement, RDTE, autonomy technologies, critical minerals, dividend share repurchase restrictions; S (not yet introduced)/HR 9495 - Department of Defense Appropriations Act, 2027 including issues related to missile defense, classified programs, strategic programs, rotary wing aircraft, attack and defensive munitions, electronic warfare technologies, aerial sensors, ground and sea-based sensors, autonomy technologies, tactical aircraft, transport aircraft, land sea and air based tactical missiles, integrated air and missile defense systems, radars and sensors, electronic warfare systems, military space, cyber, technology, intelligence, spectrum, acquisition policy, critical minerals

S 4874/HR 8800 - National Defense Authorization Act for Fiscal Year 2027 including issues related to aircraft, acquisition policy, wildland fire technology, spectrum, space, missile defense, classified and strategic programs, RDTE, defense, Army procurement, Navy procurement, Missile Defense Agency procurement, weapons, munitions, rotary wing aircraft, missile defense systems, sensors, tactical aircraft, transport aircraft, integrated air and missile defense systems, electronic warfare systems, military space, cyber, technology, intelligence, spectrum, dividend and share repurchase restrictions; S (not yet introduced)/HR 9495 - Department of Defense Appropriations Act, 2027 including issues related to aircraft, acquisition policy, space, missile defense, classified and strategic programs, tactical fixed wing aviation programs, tactical aircraft, transport aircraft, classified programs, helicopters, land sea and air based tactical missiles, integrated air and missile defense systems, radars and sensors, electronic warfare systems, military space, strategic programs, missile defense, cyber, technology, intelligence, spectrum

S 4874/HR 8800 - National Defense Authorization Act for Fiscal Year 2027 including issues related to aircraft, acquisition policy, wildland fire technology, spectrum, space, missile defense, classified and strategic programs, RDTE, defense, Army procurement, Navy procurement, Missile Defense Agency procurement, weapons, munitions, rotary wing aircraft, missile defense systems, sensors, tactical aircraft, transport aircraft, integrated air and missile defense systems, electronic warfare systems, military space, cyber, technology, intelligence, spectrum, dividend and share repurchase restrictions; S (not yet introduced)/HR 9495 - Department of Defense Appropriations Act, 2027 including issues related to aircraft, acquisition policy, space, missile defense, classified and strategic programs, tactical fixed wing aviation programs, tactical aircraft, transport aircraft, classified programs, helicopters, land sea and air based tactical missiles, integrated air and missile defense systems, radars and sensors, electronic warfare systems, military space, strategic programs, missile defense, cyber, technology, intelligence, spectrum

S 4784/HR 8800 - National Defense Authorization Act for Fiscal Year 2027 including issues related to electromagnetic spectrum, acquisition policy, missile defense, classified programs, strategic programs, tactical fixed wing aviation programs, transport aircraft, helicopters, land sea and air based tactical missiles, integrated air and radars and sensors, electronic warfare systems, military space, cyber, technology, intelligence, Foreign Military Sales (FMS), Direct Commercial Sales (DCS), procurement, RDTE, autonomy technologies, critical minerals, dividend share repurchase restrictions; S (not yet introduced)/HR 9495 - Department of Defense Appropriations Act, 2027 including issues related to missile defense, classified programs, strategic programs, rotary wing aircraft, attack and defensive munitions, electronic warfare technologies, aerial sensors, ground and sea-based sensors, autonomy technologies, tactical aircraft, transport aircraft, land sea and air based tactical missiles, integrated air and missile defense systems, radars and sensors, electronic warfare systems, military space, cyber, technology, intelligence, spectrum, acquisition policy, critical minerals

S 1173/HR 2199 - Restore Protections for Dialysis Patients Act including issues related to Medicare and secondary payer; HR 4317 - PBM Reform Act of 2025 including issues related to healthcare; HR 7148 - Consolidated Appropriations Act, 2026 including issues related to Pharmacy Benefit Manager issues

S 1173/HR 2199 - Restore Protections for Dialysis Patients Act including issues related to Medicare secondary payer issues; S 2420/HR 4710 - No Surprises Act Enforcement Act including issues related to independent dispute resolution abuse

S 2420/HR 4710 - No Surprises Act Enforcement Act including issues related to independent dispute resolution abuse; S (not yet introduced)/HR 10788 - Lower Premiums, Faster Payments Act including issues related to the appeals process

S 1173/HR 2199 - Restore Protections for Dialysis Patients Act including issues related to Medicare secondary payer issues; S 2420/HR 4710 - No Surprises Act Enforcement Act including issues related to independent dispute resolution abuse

S 4784/HR 8800 - National Defense Authorization Act for Fiscal Year 2027 including issues related to electromagnetic spectrum, acquisition policy, missile defense, classified programs, strategic programs, tactical fixed wing aviation programs, transport aircraft, helicopters, land sea and air based tactical missiles, integrated air and radars and sensors, electronic warfare systems, military space, cyber, technology, intelligence, Foreign Military Sales (FMS), Direct Commercial Sales (DCS), procurement, RDTE, autonomy technologies, critical minerals, dividend share repurchase restrictions; S (not yet introduced)/HR 9495 - Department of Defense Appropriations Act, 2027 including issues related to missile defense, classified programs, strategic programs, rotary wing aircraft, attack and defensive munitions, electronic warfare technologies, aerial sensors, ground and sea-based sensors, autonomy technologies, tactical aircraft, transport aircraft, land sea and air based tactical missiles, integrated air and missile defense systems, radars and sensors, electronic warfare systems, military space, cyber, technology, intelligence, spectrum, acquisition policy, critical minerals

S 4874/HR 8800 - National Defense Authorization Act for Fiscal Year 2027 including issues related to aircraft, acquisition policy, wildland fire technology, spectrum, space, missile defense, classified and strategic programs, RDTE, defense, Army procurement, Navy procurement, Missile Defense Agency procurement, weapons, munitions, rotary wing aircraft, missile defense systems, sensors, tactical aircraft, transport aircraft, integrated air and missile defense systems, electronic warfare systems, military space, cyber, technology, intelligence, spectrum, dividend and share repurchase restrictions; S (not yet introduced)/HR 9495 - Department of Defense Appropriations Act, 2027 including issues related to aircraft, acquisition policy, space, missile defense, classified and strategic programs, tactical fixed wing aviation programs, tactical aircraft, transport aircraft, classified programs, helicopters, land sea and air based tactical missiles, integrated air and missile defense systems, radars and sensors, electronic warfare systems, military space, strategic programs, missile defense, cyber, technology, intelligence, spectrum

HR 1062 - Growing and Preserving Innovation in America Act of 2025, including issues related foreign-derived intangible income, corporate tax rates; HR 1990 - American Innovation and R&D Competitiveness Act of 2025, including issues related to research and development expensing, preserving the deduction for employer sponsored health insurance; H.CON.RES 14 - Budget Reconciliation Act, 2026, including issues related to corporate tax issues, research and development, tax rates, foreign-derived intangible income

HR 1 - One Big Beautiful Bill Act including issues related to research and development amortization, foreign derived intangible income, spectrum, corporate alternative minimum tax

HR 1 - One Big Beautiful Bill Act including issues related research and development, foreign-derived intangible income, health savings account issues, healthcare taxation; S 1639/HR 1990 - American Innovation and Jobs Act including issues related to research and development amortization

HR 1 - One Big Beautiful Bill Act including issues related to R&D and Corporate Alternative Minimum Tax interaction, foreign-derived deduction eligible income regulations; Discussions on the implementation of Australias New Tax Reporting Regime

HR 1 - One Big Beautiful Bill Act including issues related research and development, foreign-derived intangible income, health savings account issues, healthcare taxation; S 1639/HR 1990 - American Innovation and Jobs Act including issues related to research and development amortization

HR 1062 - Growing and Preserving Innovation in America Act of 2025, including issues related foreign-derived intangible income, corporate tax rates; HR 1990 - American Innovation and R&D Competitiveness Act of 2025, including issues related to research and development expensing, preserving the deduction for employer sponsored health insurance; H.CON.RES 14 - Budget Reconciliation Act, 2026, including issues related to corporate tax issues, research and development, tax rates, foreign-derived intangible income

HR 1 - One Big Beautiful Bill Act including issues related research and development, foreign-derived intangible income, health savings account issues, healthcare taxation; S 1639/HR 1990 - American Innovation and Jobs Act including issues related to research and development amortization

HR 1062 - Growing and Preserving Innovation in America Act of 2025, including issues related foreign-derived intangible income, corporate tax rates; HR 1990 - American Innovation and R&D Competitiveness Act of 2025, including issues related to research and development expensing, preserving the deduction for employer sponsored health insurance; H.CON.RES 14 - Budget Reconciliation Act, 2026, including issues related to corporate tax issues, research and development, tax rates, foreign-derived intangible income

HR 1 - One Big Beautiful Bill Act including issues related research and development, foreign-derived intangible income, health savings account issues, healthcare taxation; S 1639/HR 1990 - American Innovation and Jobs Act including issues related to research and development amortization

HR 6703 - Lower Health Care Premiums for All Americans Act including issues related to Pharmacy Benefit Managers increased disclosure provisions

HR 1 - One Big Beautiful Bill Act including issues related research and development, foreign-derived intangible income, health savings account issues, healthcare taxation; S 1639/HR 1990 - American Innovation and Jobs Act including issues related to research and development amortization

HR 1 - One Big Beautiful Bill Act including issues related research and development, foreign-derived intangible income, health savings account issues, healthcare taxation; S 1639/HR 1990 - American Innovation and Jobs Act including issues related to research and development amortization

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to making improvements to the child tax credit, provide tax incentives to promote economic growth, specifically the provision related to the immediate deduction of the cost of U.S. based research and investment investments; S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to eliminating the five-year amortization requirement for research and experimental expenditures, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to health savings account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to health savings account modernization; HR 3561 - PATIENT Act of 2023 including issues related to pharmacy benefit manager reform and prescription drug pricing; S 127 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to pharmacy benefit manager reform and prescription drug pricing

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives to promote economic growth, specifically the provision related to the immediate deduction of the cost of U.S. based research and investment investments; S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to eliminating the five-year amortization requirement for research and experimental expenditures, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to reform and prescription drug pricing

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives to promote economic growth, specifically the immediate deduction of the cost of U.S. based research and investment investments; S 866/HR 2673 - American Innovation and R&D Competitiveness Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures, eliminating the five-year amortization requirement for research and experimental expenditures; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to reform and prescription drug pricing

S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related Pharmacy Benefit Manager reform and prescription drug pricing; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives for economic growth, improvements for the child tax credit, and eliminate the five-year amortization requirement for research and development; S 866/HR 2673 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures and eliminating the five-year amortization requirement for research and experimental expenditures

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives to promote economic growth, specifically the immediate deduction of the cost of U.S. based research and investment investments; S 866/HR 2673 - American Innovation and R&D Competitiveness Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures, eliminating the five-year amortization requirement for research and experimental expenditures; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to reform and prescription drug pricing

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to making improvements to the child tax credit, provide tax incentives to promote economic growth, specifically the provision related to the immediate deduction of the cost of U.S. based research and investment investments; S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to eliminating the five-year amortization requirement for research and experimental expenditures, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to health savings account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to health savings account modernization; HR 3561 - PATIENT Act of 2023 including issues related to pharmacy benefit manager reform and prescription drug pricing; S 127 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to pharmacy benefit manager reform and prescription drug pricing

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives to promote economic growth, specifically the provision related to the immediate deduction of the cost of U.S. based research and investment investments; S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to eliminating the five-year amortization requirement for research and experimental expenditures, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to reform and prescription drug pricing

S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related Pharmacy Benefit Manager reform and prescription drug pricing; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives for economic growth, improvements for the child tax credit, and eliminate the five-year amortization requirement for research and development; S 866/HR 2673 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures and eliminating the five-year amortization requirement for research and experimental expenditures

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to making improvements to the child tax credit, provide tax incentives to promote economic growth, specifically the provision related to the immediate deduction of the cost of U.S. based research and investment investments; S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to eliminating the five-year amortization requirement for research and experimental expenditures, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to health savings account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to health savings account modernization; HR 3561 - PATIENT Act of 2023 including issues related to pharmacy benefit manager reform and prescription drug pricing; S 127 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to pharmacy benefit manager reform and prescription drug pricing

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives to promote economic growth, specifically the immediate deduction of the cost of U.S. based research and investment investments; S 866/HR 2673 - American Innovation and R&D Competitiveness Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures, eliminating the five-year amortization requirement for research and experimental expenditures; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to reform and prescription drug pricing

S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related Pharmacy Benefit Manager reform and prescription drug pricing; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives for economic growth, improvements for the child tax credit, and eliminate the five-year amortization requirement for research and development; S 866/HR 2673 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures and eliminating the five-year amortization requirement for research and experimental expenditures

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives to promote economic growth, specifically the provision related to the immediate deduction of the cost of U.S. based research and investment investments; S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to eliminating the five-year amortization requirement for research and experimental expenditures, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to reform and prescription drug pricing

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to making improvements to the child tax credit, provide tax incentives to promote economic growth, specifically the provision related to the immediate deduction of the cost of U.S. based research and investment investments; S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to eliminating the five-year amortization requirement for research and experimental expenditures, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to health savings account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to health savings account modernization; HR 3561 - PATIENT Act of 2023 including issues related to pharmacy benefit manager reform and prescription drug pricing; S 127 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to pharmacy benefit manager reform and prescription drug pricing

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives to promote economic growth, specifically the provision related to the immediate deduction of the cost of U.S. based research and investment investments; S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to eliminating the five-year amortization requirement for research and experimental expenditures, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to reform and prescription drug pricing

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives to promote economic growth, specifically the immediate deduction of the cost of U.S. based research and investment investments; S 866/HR 2673 - American Innovation and R&D Competitiveness Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures, eliminating the five-year amortization requirement for research and experimental expenditures; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to reform and prescription drug pricing

S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related Pharmacy Benefit Manager reform and prescription drug pricing; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives for economic growth, improvements for the child tax credit, and eliminate the five-year amortization requirement for research and development; S 866/HR 2673 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures and eliminating the five-year amortization requirement for research and experimental expenditures

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to making improvements to the child tax credit, provide tax incentives to promote economic growth, specifically the provision related to the immediate deduction of the cost of U.S. based research and investment investments; S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to eliminating the five-year amortization requirement for research and experimental expenditures, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to health savings account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to health savings account modernization; HR 3561 - PATIENT Act of 2023 including issues related to pharmacy benefit manager reform and prescription drug pricing; S 127 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to pharmacy benefit manager reform and prescription drug pricing

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives to promote economic growth, specifically the immediate deduction of the cost of U.S. based research and investment investments; S 866/HR 2673 - American Innovation and R&D Competitiveness Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures, eliminating the five-year amortization requirement for research and experimental expenditures; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to reform and prescription drug pricing

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives to promote economic growth, specifically the provision related to the immediate deduction of the cost of U.S. based research and investment investments; S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to eliminating the five-year amortization requirement for research and experimental expenditures, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to reform and prescription drug pricing

S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related Pharmacy Benefit Manager reform and prescription drug pricing; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives for economic growth, improvements for the child tax credit, and eliminate the five-year amortization requirement for research and development; S 866/HR 2673 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures and eliminating the five-year amortization requirement for research and experimental expenditures

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives to promote economic growth, specifically the provision related to the immediate deduction of the cost of U.S. based research and investment investments; S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to eliminating the five-year amortization requirement for research and experimental expenditures, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to reform and prescription drug pricing

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to making improvements to the child tax credit, provide tax incentives to promote economic growth, specifically the provision related to the immediate deduction of the cost of U.S. based research and investment investments; S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to eliminating the five-year amortization requirement for research and experimental expenditures, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to health savings account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to health savings account modernization; HR 3561 - PATIENT Act of 2023 including issues related to pharmacy benefit manager reform and prescription drug pricing; S 127 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to pharmacy benefit manager reform and prescription drug pricing

S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related Pharmacy Benefit Manager reform and prescription drug pricing; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives for economic growth, improvements for the child tax credit, and eliminate the five-year amortization requirement for research and development; S 866/HR 2673 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures and eliminating the five-year amortization requirement for research and experimental expenditures

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives to promote economic growth, specifically the immediate deduction of the cost of U.S. based research and investment investments; S 866/HR 2673 - American Innovation and R&D Competitiveness Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures, eliminating the five-year amortization requirement for research and experimental expenditures; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to reform and prescription drug pricing

S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related Pharmacy Benefit Manager reform and prescription drug pricing; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives for economic growth, improvements for the child tax credit, and eliminate the five-year amortization requirement for research and development; S 866/HR 2673 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures and eliminating the five-year amortization requirement for research and experimental expenditures

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives to promote economic growth, specifically the provision related to the immediate deduction of the cost of U.S. based research and investment investments; S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to eliminating the five-year amortization requirement for research and experimental expenditures, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to reform and prescription drug pricing

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives to promote economic growth, specifically the immediate deduction of the cost of U.S. based research and investment investments; S 866/HR 2673 - American Innovation and R&D Competitiveness Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures, eliminating the five-year amortization requirement for research and experimental expenditures; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to reform and prescription drug pricing

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to making improvements to the child tax credit, provide tax incentives to promote economic growth, specifically the provision related to the immediate deduction of the cost of U.S. based research and investment investments; S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to eliminating the five-year amortization requirement for research and experimental expenditures, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to health savings account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to health savings account modernization; HR 3561 - PATIENT Act of 2023 including issues related to pharmacy benefit manager reform and prescription drug pricing; S 127 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to pharmacy benefit manager reform and prescription drug pricing

S 866/HR 1304 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and experimental expenditures to allow immediate expensing of such expenditures; increases the maximum amount eligible for the tax credit for new and small businesses and increases to 20% the rate of the credit for business startups, the corporate tax rate, pensions; S (not yet introduced)/HR (not yet introduced) - Healthcare and Paid Leave issues including prescription drug costs, paid leave, Health Savings Account Modernization and telemedicine expansion

S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to eliminating the five-year amortization requirement for research and experimental expenditures, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related reform and prescription drug pricing

S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures, Health Savings Account modernization, telemedicine expansion; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to amending the IRS Code of 1986 to restore the deduction for research and development expenditures, Health Savings Account modernization, telemedicine expansion; S 127/HR 3561 - PATIENT Act of 2023 including issues related to Pharmacy Benefit Manager reform and prescription drug pricing

S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and experimental expenditures to allow immediate expensive of such expenditures; increases the maximum amount eligible for the tax credit for small business; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to repealing sec. 174 of the tax code related to the immediate expensing of qualified research and development expenditures; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account (HSA) modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to HAS modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to Pharmacy Benefit Manager reform and prescription drug pricing

S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures, Health Savings Account modernization, telemedicine expansion; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to amending the IRS Code of 1986 to restore the deduction for research and development expenditures, Health Savings Account modernization, telemedicine expansion; S 127/HR 3561 - PATIENT Act of 2023 including issues related to Pharmacy Benefit Manager reform and prescription drug pricing

S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and experimental expenditures to allow immediate expensive of such expenditures; increases the maximum amount eligible for the tax credit for small business; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to repealing sec. 174 of the tax code related to the immediate expensing of qualified research and development expenditures; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account (HSA) modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to HAS modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to Pharmacy Benefit Manager reform and prescription drug pricing

S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to eliminating the five-year amortization requirement for research and experimental expenditures, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related reform and prescription drug pricing

S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and experimental expenditures to allow immediate expensive of such expenditures; increases the maximum amount eligible for the tax credit for small business; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to repealing sec. 174 of the tax code related to the immediate expensing of qualified research and development expenditures; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account (HSA) modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to HAS modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to Pharmacy Benefit Manager reform and prescription drug pricing

S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to eliminating the five-year amortization requirement for research and experimental expenditures, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related reform and prescription drug pricing

S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to eliminating the five-year amortization requirement for research and experimental expenditures, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related reform and prescription drug pricing

S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and experimental expenditures to allow immediate expensive of such expenditures; increases the maximum amount eligible for the tax credit for small business; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to repealing sec. 174 of the tax code related to the immediate expensing of qualified research and development expenditures; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account (HSA) modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to HAS modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to Pharmacy Benefit Manager reform and prescription drug pricing

S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and experimental expenditures to allow immediate expensive of such expenditures; increases the maximum amount eligible for the tax credit for small business; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to repealing sec. 174 of the tax code related to the immediate expensing of qualified research and development expenditures; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account (HSA) modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to HAS modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to Pharmacy Benefit Manager reform and prescription drug pricing

S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures, Health Savings Account modernization, telemedicine expansion; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to amending the IRS Code of 1986 to restore the deduction for research and development expenditures, Health Savings Account modernization, telemedicine expansion; S 127/HR 3561 - PATIENT Act of 2023 including issues related to Pharmacy Benefit Manager reform and prescription drug pricing

S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to eliminating the five-year amortization requirement for research and experimental expenditures, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related reform and prescription drug pricing

S 866/HR 1304 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and experimental expenditures to allow immediate expensing of such expenditures; increases the maximum amount eligible for the tax credit for new and small businesses and increases to 20% the rate of the credit for business startups, the corporate tax rate, pensions; S (not yet introduced)/HR (not yet introduced) - Healthcare and Paid Leave issues including prescription drug costs, paid leave, Health Savings Account Modernization and telemedicine expansion

S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and experimental expenditures to allow immediate expensive of such expenditures; increases the maximum amount eligible for the tax credit for small business; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to repealing sec. 174 of the tax code related to the immediate expensing of qualified research and development expenditures; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account (HSA) modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to HAS modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to Pharmacy Benefit Manager reform and prescription drug pricing

S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures, Health Savings Account modernization, telemedicine expansion; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to amending the IRS Code of 1986 to restore the deduction for research and development expenditures, Health Savings Account modernization, telemedicine expansion; S 127/HR 3561 - PATIENT Act of 2023 including issues related to Pharmacy Benefit Manager reform and prescription drug pricing

S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to eliminating the five-year amortization requirement for research and experimental expenditures, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related reform and prescription drug pricing

S 749/HR 1304 - American Innovation and R&D Competitiveness Act of 2021 including issues related to revising and expanding the deductibility of research and experimental expenditures to allow immediate expensing of such expenditures and increasing the maximum amount eligible for the tax credit for new and small businesses and increasing to 20% the rate of the credit for business startups, corporate tax rate, foreign derived intangible income; HR 4346 - Supreme Court Security Funding Act of 2022 including issues related to the investment in the domestic production of American-made semiconductors, including for defense products, and providing incentives for Americas scientific research and innovation; HR 5376 - Inflation Reduction Act of 2022 including issues related to imposing an alternative minimum tax of 15-percent on corporations and a one-percent excise tax on stock buybacks and to include prescription drug policy reform by lowering prescription drug prices, providing tax incentives related to clean energy and investments and tax incentives in clean energy technology, specifically long-duration batteries; HR 4830 - Pension and Budget Integrity Act of 2021 including issues related to Pension Benefit Guaranty Corporation premium education; HR 3 - Elijah E. Cummings Lower Drug Costs Now Act including issues related to healthcare, paid leave, prescription drug costs, telemedicine expansion, Health Savings Accounts modernization

S 749/HR 1304 - American Innovation and Jobs Act including issues related to the repeal of the R&D amortization provision in the tax code, pension issues, healthcare, paid leave, labor issues, telemedicine expansion, prescription drug cost issues, Health Savings Account (HSA) modernization; HR 5376 - Build Back Better Act including issues related to establishing a social safety net and social programs and to modify tax provisions, including Sec 174 that provides a four-year deferral of the R&D amortization provision, pension issues, healthcare, paid leave, labor issues, telemedicine expansion, prescription drug cost issues, HSA modernization

S 749/HR 1304 - American Innovation and R&D Competitiveness Act of 2021, including issues related to the corporate tax rate, foreign derived intangible income; S 1260/HR 4521 - United States Innovation and Competition Act of 2021, including issues related to technology and competitiveness, foreign relations, national security, domestic manufacturing, education, and trade and to focus specifically to include a provision to amend Sec. 174 including research and development amortization; HR 5376 - Build Back Better Act to establish social safety net and social programs and modifies tax provisions, including Sec. 174 that provides a four-year deferral of the R&D amortization provision; HR 4830 - Pension and Budget Integrity Act of 2021, including issues related to Pension Benefit Guaranty Corporation premium education; HR 3 - Elijah E. Cummings Lower Drug Costs Now Act, including issues related to prescription drug costs, paid leave, telemedicine expansion, health savings account modernization

S 749/HR 1304 - American Innovation and R&D Competitiveness Act of 2021 including issues related to revising and expanding the deductibility of research and experimental expenditures to allow immediate expensing of such expenditures and increasing the maximum amount eligible for the tax credit for new and small businesses and increasing to 20% the rate of the credit for business startups, corporate tax rate, foreign derived intangible income; HR 4346 - Supreme Court Security Funding Act of 2022 including issues related to the investment in the domestic production of American-made semiconductors, including for defense products, and providing incentives for Americas scientific research and innovation; HR 5376 - Inflation Reduction Act of 2022 including issues related to imposing an alternative minimum tax of 15-percent on corporations and a one-percent excise tax on stock buybacks and to include prescription drug policy reform by lowering prescription drug prices, providing tax incentives related to clean energy and investments and tax incentives in clean energy technology, specifically long-duration batteries; HR 4830 - Pension and Budget Integrity Act of 2021 including issues related to Pension Benefit Guaranty Corporation premium education; HR 3 - Elijah E. Cummings Lower Drug Costs Now Act including issues related to healthcare, paid leave, prescription drug costs, telemedicine expansion, Health Savings Accounts modernization

S 749/HR 1304 - American Innovation and Jobs Act including issues related to the repeal of the R&D amortization provision in the tax code, pension issues, healthcare, paid leave, labor issues, telemedicine expansion, prescription drug cost issues, Health Savings Account (HSA) modernization; HR 5376 - Build Back Better Act including issues related to establishing a social safety net and social programs and to modify tax provisions, including Sec 174 that provides a four-year deferral of the R&D amortization provision, pension issues, healthcare, paid leave, labor issues, telemedicine expansion, prescription drug cost issues, HSA modernization

S 749/HR 1304 - American Innovation and R&D Competitiveness Act of 2021, including issues related to the corporate tax rate, foreign derived intangible income; S 1260/HR 4521 - United States Innovation and Competition Act of 2021, including issues related to technology and competitiveness, foreign relations, national security, domestic manufacturing, education, and trade and to focus specifically to include a provision to amend Sec. 174 including research and development amortization; HR 5376 - Build Back Better Act to establish social safety net and social programs and modifies tax provisions, including Sec. 174 that provides a four-year deferral of the R&D amortization provision; HR 4830 - Pension and Budget Integrity Act of 2021, including issues related to Pension Benefit Guaranty Corporation premium education; HR 3 - Elijah E. Cummings Lower Drug Costs Now Act, including issues related to prescription drug costs, paid leave, telemedicine expansion, health savings account modernization

S 749/HR 1304 - American Innovation and Jobs Act including issues related to the repeal of the R&D amortization provision in the tax code, pension issues, healthcare, paid leave, labor issues, telemedicine expansion, prescription drug cost issues, Health Savings Account (HSA) modernization; HR 5376 - Build Back Better Act including issues related to establishing a social safety net and social programs and to modify tax provisions, including Sec 174 that provides a four-year deferral of the R&D amortization provision, pension issues, healthcare, paid leave, labor issues, telemedicine expansion, prescription drug cost issues, HSA modernization

HR 4830 - Pension and Budget Integrity Act of 2021, including issues related to pension, Pension Benefit Guaranty Corporation premium education; HR 1304 - American Innovation and R&D Competitiveness Act of 2021 including issues related to repealing the tax code related to the immediate expensing of qualified research and development expenditure or a deferral of the amortization provision be included a tax extenders package, corporate tax rate, foreign derived intangible income; S 749 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and experimental expenditures to allow immediate expensing of such expenditures or a deferral of the amortization provision be included a tax extender package, corporate tax rate, foreign derived intangible income; HR 3 - Elijah E. Cummings Lower Drug Costs Now Act, including issues related to healthcare, paid leave, prescription drug costs, telemedicine expansion, Health Savings Accounts modernization

HR 4830 - Pension and Budget Integrity Act of 2021, including issues related to pension, Pension Benefit Guaranty Corporation premium education; HR 1304 - American Innovation and R&D Competitiveness Act of 2021 including issues related to repealing the tax code related to the immediate expensing of qualified research and development expenditure or a deferral of the amortization provision be included a tax extenders package, corporate tax rate, foreign derived intangible income; S 749 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and experimental expenditures to allow immediate expensing of such expenditures or a deferral of the amortization provision be included a tax extender package, corporate tax rate, foreign derived intangible income; HR 3 - Elijah E. Cummings Lower Drug Costs Now Act, including issues related to healthcare, paid leave, prescription drug costs, telemedicine expansion, Health Savings Accounts modernization

S 749/HR 1304 - American Innovation and R&D Competitiveness Act of 2021 including issues related to revising and expanding the deductibility of research and experimental expenditures to allow immediate expensing of such expenditures and increasing the maximum amount eligible for the tax credit for new and small businesses and increasing to 20% the rate of the credit for business startups, corporate tax rate, foreign derived intangible income; HR 4346 - Supreme Court Security Funding Act of 2022 including issues related to the investment in the domestic production of American-made semiconductors, including for defense products, and providing incentives for Americas scientific research and innovation; HR 5376 - Inflation Reduction Act of 2022 including issues related to imposing an alternative minimum tax of 15-percent on corporations and a one-percent excise tax on stock buybacks and to include prescription drug policy reform by lowering prescription drug prices, providing tax incentives related to clean energy and investments and tax incentives in clean energy technology, specifically long-duration batteries; HR 4830 - Pension and Budget Integrity Act of 2021 including issues related to Pension Benefit Guaranty Corporation premium education; HR 3 - Elijah E. Cummings Lower Drug Costs Now Act including issues related to healthcare, paid leave, prescription drug costs, telemedicine expansion, Health Savings Accounts modernization

S 749/HR 1304 - American Innovation and R&D Competitiveness Act of 2021, including issues related to the corporate tax rate, foreign derived intangible income; S 1260/HR 4521 - United States Innovation and Competition Act of 2021, including issues related to technology and competitiveness, foreign relations, national security, domestic manufacturing, education, and trade and to focus specifically to include a provision to amend Sec. 174 including research and development amortization; HR 5376 - Build Back Better Act to establish social safety net and social programs and modifies tax provisions, including Sec. 174 that provides a four-year deferral of the R&D amortization provision; HR 4830 - Pension and Budget Integrity Act of 2021, including issues related to Pension Benefit Guaranty Corporation premium education; HR 3 - Elijah E. Cummings Lower Drug Costs Now Act, including issues related to prescription drug costs, paid leave, telemedicine expansion, health savings account modernization

S 749/HR 1304 - American Innovation and R&D Competitiveness Act of 2021 including issues related to revising and expanding the deductibility of research and experimental expenditures to allow immediate expensing of such expenditures and increasing the maximum amount eligible for the tax credit for new and small businesses and increasing to 20% the rate of the credit for business startups, corporate tax rate, foreign derived intangible income; HR 4346 - Supreme Court Security Funding Act of 2022 including issues related to the investment in the domestic production of American-made semiconductors, including for defense products, and providing incentives for Americas scientific research and innovation; HR 5376 - Inflation Reduction Act of 2022 including issues related to imposing an alternative minimum tax of 15-percent on corporations and a one-percent excise tax on stock buybacks and to include prescription drug policy reform by lowering prescription drug prices, providing tax incentives related to clean energy and investments and tax incentives in clean energy technology, specifically long-duration batteries; HR 4830 - Pension and Budget Integrity Act of 2021 including issues related to Pension Benefit Guaranty Corporation premium education; HR 3 - Elijah E. Cummings Lower Drug Costs Now Act including issues related to healthcare, paid leave, prescription drug costs, telemedicine expansion, Health Savings Accounts modernization

S 749/HR 1304 - American Innovation and R&D Competitiveness Act of 2021, including issues related to the corporate tax rate, foreign derived intangible income; S 1260/HR 4521 - United States Innovation and Competition Act of 2021, including issues related to technology and competitiveness, foreign relations, national security, domestic manufacturing, education, and trade and to focus specifically to include a provision to amend Sec. 174 including research and development amortization; HR 5376 - Build Back Better Act to establish social safety net and social programs and modifies tax provisions, including Sec. 174 that provides a four-year deferral of the R&D amortization provision; HR 4830 - Pension and Budget Integrity Act of 2021, including issues related to Pension Benefit Guaranty Corporation premium education; HR 3 - Elijah E. Cummings Lower Drug Costs Now Act, including issues related to prescription drug costs, paid leave, telemedicine expansion, health savings account modernization

S 749/HR 1304 - American Innovation and R&D Competitiveness Act of 2021 including issues related to revising and expanding the deductibility of research and experimental expenditures to allow immediate expensing of such expenditures and increasing the maximum amount eligible for the tax credit for new and small businesses and increasing to 20% the rate of the credit for business startups, corporate tax rate, foreign derived intangible income; HR 4346 - Supreme Court Security Funding Act of 2022 including issues related to the investment in the domestic production of American-made semiconductors, including for defense products, and providing incentives for Americas scientific research and innovation; HR 5376 - Inflation Reduction Act of 2022 including issues related to imposing an alternative minimum tax of 15-percent on corporations and a one-percent excise tax on stock buybacks and to include prescription drug policy reform by lowering prescription drug prices, providing tax incentives related to clean energy and investments and tax incentives in clean energy technology, specifically long-duration batteries; HR 4830 - Pension and Budget Integrity Act of 2021 including issues related to Pension Benefit Guaranty Corporation premium education; HR 3 - Elijah E. Cummings Lower Drug Costs Now Act including issues related to healthcare, paid leave, prescription drug costs, telemedicine expansion, Health Savings Accounts modernization

S 749/HR 1304 - American Innovation and R&D Competitiveness Act of 2021 including issues related to revising and expanding the deductibility of research and experimental expenditures to allow immediate expensing of such expenditures and increasing the maximum amount eligible for the tax credit for new and small businesses and increasing to 20% the rate of the credit for business startups, corporate tax rate, foreign derived intangible income; HR 4346 - Supreme Court Security Funding Act of 2022 including issues related to the investment in the domestic production of American-made semiconductors, including for defense products, and providing incentives for Americas scientific research and innovation; HR 5376 - Inflation Reduction Act of 2022 including issues related to imposing an alternative minimum tax of 15-percent on corporations and a one-percent excise tax on stock buybacks and to include prescription drug policy reform by lowering prescription drug prices, providing tax incentives related to clean energy and investments and tax incentives in clean energy technology, specifically long-duration batteries; HR 4830 - Pension and Budget Integrity Act of 2021 including issues related to Pension Benefit Guaranty Corporation premium education; HR 3 - Elijah E. Cummings Lower Drug Costs Now Act including issues related to healthcare, paid leave, prescription drug costs, telemedicine expansion, Health Savings Accounts modernization

S 749/HR 1304 - American Innovation and R&D Competitiveness Act of 2021, including issues related to the corporate tax rate, foreign derived intangible income; S 1260/HR 4521 - United States Innovation and Competition Act of 2021, including issues related to technology and competitiveness, foreign relations, national security, domestic manufacturing, education, and trade and to focus specifically to include a provision to amend Sec. 174 including research and development amortization; HR 5376 - Build Back Better Act to establish social safety net and social programs and modifies tax provisions, including Sec. 174 that provides a four-year deferral of the R&D amortization provision; HR 4830 - Pension and Budget Integrity Act of 2021, including issues related to Pension Benefit Guaranty Corporation premium education; HR 3 - Elijah E. Cummings Lower Drug Costs Now Act, including issues related to prescription drug costs, paid leave, telemedicine expansion, health savings account modernization

S 749/HR 1304 - American Innovation and R&D Competitiveness Act of 2021, including issues related to the corporate tax rate, foreign derived intangible income; S 1260/HR 4521 - United States Innovation and Competition Act of 2021, including issues related to technology and competitiveness, foreign relations, national security, domestic manufacturing, education, and trade and to focus specifically to include a provision to amend Sec. 174 including research and development amortization; HR 5376 - Build Back Better Act to establish social safety net and social programs and modifies tax provisions, including Sec. 174 that provides a four-year deferral of the R&D amortization provision; HR 4830 - Pension and Budget Integrity Act of 2021, including issues related to Pension Benefit Guaranty Corporation premium education; HR 3 - Elijah E. Cummings Lower Drug Costs Now Act, including issues related to prescription drug costs, paid leave, telemedicine expansion, health savings account modernization

HR 4830 - Pension and Budget Integrity Act of 2021, including issues related to pension, Pension Benefit Guaranty Corporation premium education; HR 1304 - American Innovation and R&D Competitiveness Act of 2021 including issues related to repealing the tax code related to the immediate expensing of qualified research and development expenditure or a deferral of the amortization provision be included a tax extenders package, corporate tax rate, foreign derived intangible income; S 749 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and experimental expenditures to allow immediate expensing of such expenditures or a deferral of the amortization provision be included a tax extender package, corporate tax rate, foreign derived intangible income; HR 3 - Elijah E. Cummings Lower Drug Costs Now Act, including issues related to healthcare, paid leave, prescription drug costs, telemedicine expansion, Health Savings Accounts modernization

S 749/HR 1304 - American Innovation and R&D Competitiveness Act of 2021 including issues related to revising and expanding the deductibility of research and experimental expenditures to allow immediate expensing of such expenditures and increasing the maximum amount eligible for the tax credit for new and small businesses and increasing to 20% the rate of the credit for business startups, corporate tax rate, foreign derived intangible income; HR 4346 - Supreme Court Security Funding Act of 2022 including issues related to the investment in the domestic production of American-made semiconductors, including for defense products, and providing incentives for Americas scientific research and innovation; HR 5376 - Inflation Reduction Act of 2022 including issues related to imposing an alternative minimum tax of 15-percent on corporations and a one-percent excise tax on stock buybacks and to include prescription drug policy reform by lowering prescription drug prices, providing tax incentives related to clean energy and investments and tax incentives in clean energy technology, specifically long-duration batteries; HR 4830 - Pension and Budget Integrity Act of 2021 including issues related to Pension Benefit Guaranty Corporation premium education; HR 3 - Elijah E. Cummings Lower Drug Costs Now Act including issues related to healthcare, paid leave, prescription drug costs, telemedicine expansion, Health Savings Accounts modernization

S 749/HR 1304 - American Innovation and R&D Competitiveness Act of 2021, including issues related to the corporate tax rate, foreign derived intangible income; S 1260/HR 4521 - United States Innovation and Competition Act of 2021, including issues related to technology and competitiveness, foreign relations, national security, domestic manufacturing, education, and trade and to focus specifically to include a provision to amend Sec. 174 including research and development amortization; HR 5376 - Build Back Better Act to establish social safety net and social programs and modifies tax provisions, including Sec. 174 that provides a four-year deferral of the R&D amortization provision; HR 4830 - Pension and Budget Integrity Act of 2021, including issues related to Pension Benefit Guaranty Corporation premium education; HR 3 - Elijah E. Cummings Lower Drug Costs Now Act, including issues related to prescription drug costs, paid leave, telemedicine expansion, health savings account modernization

S 749/HR 1304 - American Innovation and R&D Competitiveness Act of 2021 including issues related to revising and expanding the deductibility of research and experimental expenditures to allow immediate expensing of such expenditures and increasing the maximum amount eligible for the tax credit for new and small businesses and increasing to 20% the rate of the credit for business startups, corporate tax rate, foreign derived intangible income; HR 4346 - Supreme Court Security Funding Act of 2022 including issues related to the investment in the domestic production of American-made semiconductors, including for defense products, and providing incentives for Americas scientific research and innovation; HR 5376 - Inflation Reduction Act of 2022 including issues related to imposing an alternative minimum tax of 15-percent on corporations and a one-percent excise tax on stock buybacks and to include prescription drug policy reform by lowering prescription drug prices, providing tax incentives related to clean energy and investments and tax incentives in clean energy technology, specifically long-duration batteries; HR 4830 - Pension and Budget Integrity Act of 2021 including issues related to Pension Benefit Guaranty Corporation premium education; HR 3 - Elijah E. Cummings Lower Drug Costs Now Act including issues related to healthcare, paid leave, prescription drug costs, telemedicine expansion, Health Savings Accounts modernization

S 749/HR 1304 - American Innovation and R&D Competitiveness Act of 2021, including issues related to the corporate tax rate, foreign derived intangible income; S 1260/HR 4521 - United States Innovation and Competition Act of 2021, including issues related to technology and competitiveness, foreign relations, national security, domestic manufacturing, education, and trade and to focus specifically to include a provision to amend Sec. 174 including research and development amortization; HR 5376 - Build Back Better Act to establish social safety net and social programs and modifies tax provisions, including Sec. 174 that provides a four-year deferral of the R&D amortization provision; HR 4830 - Pension and Budget Integrity Act of 2021, including issues related to Pension Benefit Guaranty Corporation premium education; HR 3 - Elijah E. Cummings Lower Drug Costs Now Act, including issues related to prescription drug costs, paid leave, telemedicine expansion, health savings account modernization

S 749/HR 1304 - American Innovation and R&D Competitiveness Act of 2021 including issues related to revising and expanding the deductibility of research and experimental expenditures to allow immediate expensing of such expenditures and increasing the maximum amount eligible for the tax credit for new and small businesses and increasing to 20% the rate of the credit for business startups, corporate tax rate, foreign derived intangible income; HR 4346 - Supreme Court Security Funding Act of 2022 including issues related to the investment in the domestic production of American-made semiconductors, including for defense products, and providing incentives for Americas scientific research and innovation; HR 5376 - Inflation Reduction Act of 2022 including issues related to imposing an alternative minimum tax of 15-percent on corporations and a one-percent excise tax on stock buybacks and to include prescription drug policy reform by lowering prescription drug prices, providing tax incentives related to clean energy and investments and tax incentives in clean energy technology, specifically long-duration batteries; HR 4830 - Pension and Budget Integrity Act of 2021 including issues related to Pension Benefit Guaranty Corporation premium education; HR 3 - Elijah E. Cummings Lower Drug Costs Now Act including issues related to healthcare, paid leave, prescription drug costs, telemedicine expansion, Health Savings Accounts modernization

S 749/HR 1304 - American Innovation and Jobs Act including issues related to the repeal of the R&D amortization provision in the tax code, pension issues, healthcare, paid leave, labor issues, telemedicine expansion, prescription drug cost issues, Health Savings Account (HSA) modernization; HR 5376 - Build Back Better Act including issues related to establishing a social safety net and social programs and to modify tax provisions, including Sec 174 that provides a four-year deferral of the R&D amortization provision, pension issues, healthcare, paid leave, labor issues, telemedicine expansion, prescription drug cost issues, HSA modernization

S 749/HR 1304 - American Innovation and R&D Competitiveness Act of 2021, including issues related to the corporate tax rate, foreign derived intangible income; S 1260/HR 4521 - United States Innovation and Competition Act of 2021, including issues related to technology and competitiveness, foreign relations, national security, domestic manufacturing, education, and trade and to focus specifically to include a provision to amend Sec. 174 including research and development amortization; HR 5376 - Build Back Better Act to establish social safety net and social programs and modifies tax provisions, including Sec. 174 that provides a four-year deferral of the R&D amortization provision; HR 4830 - Pension and Budget Integrity Act of 2021, including issues related to Pension Benefit Guaranty Corporation premium education; HR 3 - Elijah E. Cummings Lower Drug Costs Now Act, including issues related to prescription drug costs, paid leave, telemedicine expansion, health savings account modernization